Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
20 Years to 85 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient who have been diagnosed with sleep disordered breathing (apnea or Cheyne-Stokes respiration)
Able to understand and sign the informed consent
Able to comply with visits and follow ups included in this protocol
Ages 20-85 years
An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.
Skin rash on the nose or on the maxillary area.
A history of skin allergy to medical tape, and hypoallergenic tapes.
A history of skin cancer on the nose or on the maxillary area.
A history of the base of skull fractures, facial fractures